Nasonex spray 120 doses

Nasonex spray 120 doses

Composition

Each actuation contains:

Mometasone furoate monohydrate 0.05% (equivalent to 50 micrograms of mometasone furoate per spray)

Description

Nasonex is a prescription-strength nasal spray formulated with mometasone furoate, a potent corticosteroid with anti-inflammatory properties. Designed to treat symptoms of seasonal and perennial allergic rhinitis, as well as nasal polyps in adults, it delivers precise doses of medication through a scent-free aqueous spray. Clinically proven, Nasonex effectively relieves congestion, sneezing, and runny nose while helping to reduce inflammation in the nasal passages. It starts to work within 12 hours for some patients and provides continuous relief with regular use.

Indications for Use

-Treatment and prevention of symptoms of seasonal and perennial allergic rhinitis in adults and children aged 3 years and older

-Treatment of nasal polyps in adults (18 years and older)

-Reduction of nasal inflammation associated with allergies

-Protection of nasal passages from allergens

Dosage and Method of Administration

-Adults and children ≥12 years (Rhinitis):

2 sprays in each nostril once daily (total 200 micrograms/day)

Once symptoms are controlled, reduce to 1 spray per nostril daily

-Children aged 3–11 years:

1 spray in each nostril once daily (total 100 micrograms/day)

-Nasal Polyps in adults:

Initial: 2 sprays in each nostril once daily

-If symptoms persist after 5–6 weeks: increase to 2 sprays in each nostril twice daily (maximum 400 micrograms/day)

-Shake well before use. If unused for 14 days or more, re-prime the pump with 2 sprays.

Contraindications

-Hypersensitivity to mometasone furoate or any excipients

-Untreated local nasal infections (e.g. herpes simplex)

-Recent nasal surgery or trauma (until healing occurs)

Precautions

-Use with caution in patients with tuberculosis, fungal or systemic infections

-May cause growth suppression in children with prolonged use

-Monitor intraocular pressure in patients at risk of glaucoma or cataracts

-Avoid use in presence of nasal ulcers or perforation of nasal septum

-Contains benzalkonium chloride, which may cause nasal irritation with long-term use

-Use with caution in immunocompromised patients

-Not recommended during pregnancy or breastfeeding unless clearly needed

Side Effects

Common:

Headache

Epistaxis (nosebleeds)

Nasal irritation or burning

Pharyngitis

Less common / Rare:

Nasal ulceration

Nasal septum perforation

Glaucoma or increased intraocular pressure

Vision disturbances

Hypersensitivity reactions (e.g., rash, angioedema, bronchospasm)

Cushingoid features with prolonged high-dose use

Pregnancy and Breastfeeding

Classified as pregnancy category C. Use only if clearly needed and under medical supervision. Safety during breastfeeding has not been established; consult a doctor before use.

Storage Conditions

Store at room temperature

Keep out of reach of children

Do not expose to direct sunlight or moisture

Discard 2 months after first use or after 120 actuations

Packaging

Carton box includes spray unit and package insert.